Investors Invest in the Full Realization of Industrial Hemp as the Billion-Dollar Crop
The Hemp-BioRefinery offers accredited investors a unique opportunity to participate in a proven, zero-waste biorefinery platform specialized for industrial hemp. By recovering every valuable fraction of the plant — including proteins, oils, fibers, sugars, biofuels, bioplastics, organic fertilizer, and the rich spectrum of embedded phytochemicals and nutraceuticals — the platform creates multiple high-margin revenue streams while advancing regenerative agriculture and rural economic development.
Investment Opportunity Summary
The Hemp-BioRefinery is the industrial-hemp specialization of the Community BioRefinery (CBR) platform — one of the oldest privately held biofuels R&D organizations in the United States. The technology has been refined over more than four decades and successfully demonstrated on multiple organic feedstocks. Applied to industrial hemp, it enables complete utilization of the whole plant, transforming a versatile crop into a diversified portfolio of food, nutraceutical, material, fuel, and fertilizer products.
Key investment highlights include:
- Full-plant valorization of industrial hemp, including high-value phytochemicals and nutraceuticals
- Zero-waste, no-heat, no-chemical process aligned with circular-economy principles
- Modular, scalable design that can be deployed near growing regions
- Strong alignment with growing demand for sustainable proteins, bioplastics, advanced biofuels, and regenerative agriculture solutions
- Experienced leadership team with deep technical, operational, and capital-formation expertise
This is a platform investment in the commercialization of a mature technology applied to one of the most versatile regenerative crops available today.
.
Financial Highlights / Projections
Detailed financial projections, unit economics, and sensitivity analyses are contained in the Private Placement Memorandum (PPM) and supporting Business Plan.
At a high level, the model is built on multiple concurrent revenue streams from a single industrial hemp feedstock:
- Premium BCAA protein isolates and high-oleic oils
- Specialty fibers and resistant starch
- Bio-butanol and related biochemicals
- Phytochemical and nutraceutical extracts
- Bioplastics precursors (PLA/PHA based pathways)
- Zymobec Spectrum XTTM organic fertilizer
Because every major fraction of the plant is monetized, the platform is designed to deliver stronger overall margins and greater resilience than single-product hemp processing facilities. Revenue diversity also reduces exposure to price volatility in any one market segment.
Investors are strongly encouraged to review the full financial model and assumptions in the PPM.
Scalability and Expansion Plans
The Community BioRefinery platform is intentionally modular. Individual facilities can be sized to match local industrial hemp production and scaled or replicated as feedstock availability and market demand growth.
Expansion strategy focuses on:
- Establishing initial community-scale facilities in key industrial hemp growing regions
- Securing long-term offtake agreements with growers and end-product buyers
- Replicating successful sites to create a distributed network of biorefineries
- Continuous technology improvement in protein isolation, phytochemical recovery, fermentation efficiency, and process automation (CBR CORE AI Support Hub))
This approach allows disciplined capital deployment while building a geographically diversified portfolio of operating assets that strengthen local agricultural economies.
While scalable, CBR management has determined that unlimited scaling of the facilities becomes counterproductive and will affect the overall productivity of the particular facility. Further, the overall modeling of the CBR facility submitted for USDA ASPEN feasibility evaluation clearly indicated the likely limitations that would occur should the process facility be expanded too much.
Use of Proceeds
Proceeds from the current offering are intended to advance commercialization of the Hemp-BioRefinery platform. Primary uses include:
- Detailed engineering, permitting, and construction of initial commercial-scale facilities
- Procurement and installation of Mechanical Reduction Technology (MRT) and continuous fermentation systems
- Working capital for operations, feedstock procurement, and product inventory
- Further optimization of phytochemical and nutraceutical recovery processes
- Team expansion in operations, quality control, and commercial development
- General corporate purposes supporting platform growth
A detailed allocation of sourced and uses is provided in the Private Placement Memorandum.
How to Participate (Accredited Investors Only)
Participation is limited to accredited investors as defined under Regulation D of the Securities Act of 1933.
For Accredited Investors — see CBRJointVentures .com
Interested parties should:
- Visit CBR Joint Ventures.com for current opportunities
- Contact the company to request the Private Placement Memorandum (PPM) and Business Plan
- Complete the investor questionnaire and accreditation verification process
- Review all offering documents carefully, including risk factors
- Execute the required subscription documents if they elect to invest
For inquiries, please contact: [email protected]
PPM / Business Plan Download
The complete Private Placement Memorandum, Business Plan, financial model, and related offering documents are available upon request to qualified accredited investors through CBRJointVentures.com or by contacting the company directly. Access is granted only after preliminary screening and execution of any required confidentiality agreements.
Risk Factors & Disclaimer
Important Legal Notice
This is not an offer to sell securities. Investments involve risk of loss of principal, including the possible complete loss of invested capital. The material on this website is for informational purposes only and does not constitute an offer, solicitation, or recommendation to buy or sell any securities.
Only accredited investors who have received, reviewed, and understood the full Private Placement Memorandum (PPM), Business Plan, and related offering documents, and who have completed proper vetting and accreditation verification, may participate.
Prospective investors should carefully consider the risk factors described in the PPM, which include, but are not limited to, technology scale-up risk, feedstock availability and pricing, regulatory and compliance risks related to industrial hemp, market acceptance of new products (including phytochemical and nutraceutical extracts), competition, operational execution risk, and general economic conditions.
Past performance of related technologies or pilot projects is not indicative of future results. Forward-looking statements are based on current expectations and are subject to change.
See full details, risk factors, and offering terms in the Private Placement Memorandum.
This is not an offer to sell securities.
Investments involve risk of loss of principal. The material on this website is for informational purposes only. Only accredited investors who have reviewed the Private Placement Memorandum (PPM), Business Plan, and completed proper vetting may participate. See full details in the PPM.